Rochester, Minnesota
Colorectal cancer clinical trials in Rochester, MN
30 colorectal cancer studies are recruiting participants at sites in Rochester as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Rochester at a glance
- 30 studies are recruiting at a site in Rochester.
- By phase: Phase 1 (8), Phase 1/2 (9), Phase 2 (2), Phase 3 (3), No phase (2), Observational (6). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (24), university, hospital or other (6).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Rochester
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT05863195 · updated
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Mayo Clinic in Rochester, Minnesota ( Site 0091)
- Registry record
- NCT06997497 · updated
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Mayo Clinic Rochester
- Registry record
- NCT04929223 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT05080673 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- Mayo Clinic
- Registry record
- NCT06418204 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Mayo Clinic - Rochester
- Registry record
- NCT07213791 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Mayo Clinic, Rochester
- Registry record
- NCT06720987 · updated
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Mayo Clinic in Rochester, Minnesota
- Registry record
- NCT06710756 · updated
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Mayo Clinic Rochester
- Registry record
- NCT04981119 · updated
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Study site
- Mayo Clinic
- Registry record
- NCT06973564 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Mayo Clinic (Minnesota)
- Registry record
- NCT04657068 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Mayo Clinic Comprehensive Cancer Center
- Registry record
- NCT06026410 · updated
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Mayo Clinic-Rochester /ID# 273508
- Registry record
- NCT07023289 · updated
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Mayo Clinic · Mayo Clinic Cancer Center Outpatient Pharmacy · Mayo Clinic Hospital, Methodist Campus, Research Pharmacy
- Registry record
- NCT07222800 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT05919264 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #68
- Registry record
- NCT05176483 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT06445062 · updated
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Guardant Health, Inc.
- Study site
- Mayo Clinic (Rochester)
- Registry record
- NCT05059444 · updated
Safety of HRX215 in Patients After Minor and Major Liver Resection
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- HepaRegeniX GmbH
- Study site
- Mayo Clinic
- Registry record
- NCT06638502 · updated
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic
- Registry record
- NCT05410977 · updated
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Xencor, Inc.
- Study site
- Xencor Investigative Site
- Registry record
- NCT05433142 · updated
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Phase 1
- Ages 18 to 100
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Mayo Clinic Rochester
- Registry record
- NCT06562192 · updated
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study sites
- Mayo Clinic · Mayo Clinic Cancer Center
- Registry record
- NCT06131840 · updated
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Study site
- May Clinic Rochester
- Registry record
- NCT06948448 · updated
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- New Phase Ltd.
- Study site
- Mayo Clinic
- Registry record
- NCT07224464 · updated
Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer
- Observational
- Ages 18 to 99
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT06965166 · updated
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- 858 Therapeutics, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT06395519 · updated
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Rochester
- Registry record
- NCT06349642 · updated
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT06682793 · updated
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- GI Innovation, Inc.
- Study site
- Mayo Clinic in Minnesota
- Registry record
- NCT05824975 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Rochester, MN on ClinicalTrials.gov.
Ask about studies near Rochester
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Minnesota
All Minnesota locations
61 studies recruiting across 47 cities.
Minneapolis
24 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections